Weight Loss

Retatrutide

Triple Agonist (GLP-1/GIP/Glucagon)

Next-generation triple receptor agonist β€” the most talked-about research peptide of 2026.

Vial10mg
MW4731 Da
Common research dose2000 mcg
$279.99

Checkout launches soon β€” tap Add to Cart to join the waitlist. Run reconstitution calculator β†’

About Retatrutide

Next-generation triple receptor agonist β€” the most talked-about research peptide of 2026. Also known as Triple Agonist (GLP-1/GIP/Glucagon).

Retatrutide is supplied as a lyophilized powder in a 10mg vial. Commonly referenced research protocols reconstitute with 2ml of bacteriostatic water, yielding a concentration of 5000 mcg/ml.

Reconstitution reference

Using 2ml bacteriostatic water in a 10mg vial produces 5000 mcg/ml. A 2000mcg research dose = 40.0 IU on a U-100 insulin syringe.

Open calculator with Retatrutide preloaded

Related peptides

Semaglutide

GLP-1 Agonist

Long-acting GLP-1 receptor agonist widely studied for metabolic and appetite research.

5mg vial $149.99

Tirzepatide

Dual GLP-1 / GIP

Dual GLP-1 / GIP receptor agonist β€” the next generation of incretin research compounds.

10mg vial $219.99

Research Use Only. All products sold are for laboratory research purposes only. Not for human consumption, diagnostic use, or therapeutic use. Must be 21+ to purchase.